The US newborn screening market is supported by established public-health screening programs and continued investment in early detection technologies. Newborns are routinely screened for selected genetic, metabolic, endocrine, hearing, and congenital heart conditions. Increasing attention to early diagnosis and intervention is supporting demand for advanced screening systems. The Newborn...